Monday, August 31, 2026

Gyrodyne Stock Went Up By Over 15% In The Last 5 Sessions

ViaNews Editorial Team

February 1, 2023

Gyrodyne Stock Went Up By Over 15% In The Last 5 Sessions

(VIANEWS) - Shares of Gyrodyne (NASDAQ: GYRO) rose by a staggering 15.38% in 5 sessions from $7.8 at 15.38, to $9.00 at 11:13 EST on Wednesday, after two consecutive sessions in a row of losses. NASDAQ is dropping 0.27% to $11,553.25, following the last session's upward trend.

Gyrodyne's last close was $9.05, 39.14% below its 52-week high of $14.87.

About Gyrodyne

Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.

Earnings Per Share

As for profitability, Gyrodyne has a trailing twelve months EPS of $-2.53.

Yearly Top and Bottom Value

Gyrodyne's stock is valued at $9.00 at 11:13 EST, way under its 52-week high of $14.87 and way higher than its 52-week low of $8.10.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 2.74M for the twelve trailing months.

Volume

Today's last reported volume for Gyrodyne is 699 which is 77.19% below its average volume of 1320.

More news about Gyrodyne (GYRO).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com